Sale!

COL2A1 Gene Avascular Necrosis of the Femoral Head Primary Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “COL2A1 Gene Avascular Necrosis of the Femoral Head Primary Genetic Test” is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the COL2A1 gene, which are associated with an increased risk of developing avascular necrosis of the femoral head (AVN). AVN is a condition characterized by the death of bone tissue due to a lack of blood supply, leading to pain and potential collapse of the femoral head. The COL2A1 gene plays a crucial role in the production of type II collagen, a vital component of cartilage and the bone matrix. Mutations in this gene can disrupt the normal formation and maintenance of bone tissue, contributing to the development of AVN.

This genetic test is particularly valuable for individuals with a family history of AVN or those exhibiting early symptoms of the condition, offering a proactive approach to diagnosis and management. By identifying specific genetic mutations, healthcare providers can better understand an individual’s risk profile, tailor treatments, and potentially implement preventive measures to mitigate the progression of AVN.

The test is priced at 4400 AED and is conducted at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any mutations in the COL2A1 gene. Results from this test can provide crucial information for both patients and clinicians in the management of avascular necrosis of the femoral head, offering insights that can lead to more personalized and effective care strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

COL2A1 Gene Avascular necrosis of the femoral head primary Genetic Test

Test Name: COL2A1 Gene Avascular necrosis of the femoral head primary Genetic Test

Components: COL2A1 gene analysis

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for COL2A1 Gene Avascular necrosis of the femoral head, primary NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL2A1 Gene Avascular necrosis of the femoral head, primary NGS Genetic DNA Test gene COL2A1

Test Details: The COL2A1 gene is responsible for providing instructions for the production of type II collagen, which is a protein found in connective tissues such as cartilage and the vitreous humor of the eye. Mutations in the COL2A1 gene have been associated with a range of disorders known as type II collagenopathies. Avascular necrosis of the femoral head, also known as osteonecrosis or aseptic necrosis, is a condition characterized by the death of bone tissue in the femoral head due to a lack of blood supply. This can lead to pain, stiffness, and eventually joint collapse. Primary NGS (Next-Generation Sequencing) genetic testing refers to the use of advanced sequencing technologies to analyze multiple genes simultaneously. In the context of avascular necrosis of the femoral head, primary NGS genetic testing can be used to identify mutations or variants in the COL2A1 gene that may be associated with the condition. By analyzing the genetic makeup of an individual using NGS technology, healthcare professionals can identify specific mutations or variants in the COL2A1 gene that may contribute to the development of avascular necrosis of the femoral head. This information can help in diagnosing the condition, understanding its underlying causes, and potentially guiding treatment decisions. It is important to note that avascular necrosis of the femoral head can have various causes, including trauma, steroid use, alcohol abuse, and other genetic factors. Therefore, while genetic testing can provide valuable insights, it is typically used in conjunction with other diagnostic methods to determine the underlying cause of the condition.

Test Name COL2A1 Gene Avascular necrosis of the femoral head primary Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for COL2A1 Gene Avascular necrosis of the femoral head, primary NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL2A1 Gene Avascular necrosis of the femoral head, primary NGS Genetic DNA Test gene COL2A1
Test Details

The COL2A1 gene is responsible for providing instructions for the production of type II collagen, which is a protein found in connective tissues such as cartilage and the vitreous humor of the eye. Mutations in the COL2A1 gene have been associated with a range of disorders known as type II collagenopathies.

Avascular necrosis of the femoral head, also known as osteonecrosis or aseptic necrosis, is a condition characterized by the death of bone tissue in the femoral head due to a lack of blood supply. This can lead to pain, stiffness, and eventually joint collapse.

Primary NGS (Next-Generation Sequencing) genetic testing refers to the use of advanced sequencing technologies to analyze multiple genes simultaneously. In the context of avascular necrosis of the femoral head, primary NGS genetic testing can be used to identify mutations or variants in the COL2A1 gene that may be associated with the condition.

By analyzing the genetic makeup of an individual using NGS technology, healthcare professionals can identify specific mutations or variants in the COL2A1 gene that may contribute to the development of avascular necrosis of the femoral head. This information can help in diagnosing the condition, understanding its underlying causes, and potentially guiding treatment decisions.

It is important to note that avascular necrosis of the femoral head can have various causes, including trauma, steroid use, alcohol abuse, and other genetic factors. Therefore, while genetic testing can provide valuable insights, it is typically used in conjunction with other diagnostic methods to determine the underlying cause of the condition.